✨ Free AI Report
Gritstone bio, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Gritstone bio, Inc.
Research Preview

Gritstone bio, Inc.: Business Overview, Financials & Competitive Analysis

Gritstone bio discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. The company uses self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd) vect...

Analyst-debate audio for Gritstone bio, Inc.

AskCyborg analysts argue the bull and bear cases for Gritstone bio, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Gritstone bio, Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
2/ 10Challenged

Cyborg Score thesis

Early-stage immunotherapy platform with promising science undermined by critical financial failure and delisted...

Read the full analyst-debate transcript →
Industry Biotechnology - Immunotherapy & Oncology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: July 13, 2026
AI-Verified Research
30+ Page Report

Get the Latest Gritstone bio, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Gritstone bio, Inc. Overview

Pro stress-test →

Gritstone bio discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. The company uses self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd) vectors to elicit desired immune responses. The company faces severe financial distress following bankruptcy restructuring.

Strategic Profile

Pro stress-test →

The company's two oncology programs in clinical-stage development are GRANITE, an individualized neoantigen-based immunotherapy, and SLATE, an off-the-shelf shared neoantigen-based immunotherapy. The company has also developed a COVID-19 vaccine candidate supported by U.S. government contracts and is researching a functional cure for HIV in collaboration with the National Institutes of Health.

Competitive Landscape

Pro stress-test →

Gritstone competes in the personalized cancer immunotherapy and vaccine development space against larger, better-capitalized biotechs including Moderna, BioNTech, and Inovio. However, bankruptcy and delisting have effectively removed it from active competition. The company's neoantigen-personalized approach competes conceptually with similar therapies from larger oncology platforms.

Industry Context

Gritstone bio, Inc. operates in Biotechnology - Immunotherapy & Oncology.

Key facts

Founded: 2015 · Headquarters: Emeryville, US · Market cap: $3.8M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Gritstone bio, Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Gritstone bio, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

ModernamRNA-based therapeutics and vaccinesBioNTechPersonalized neoantigen immunotherapiesInovioDNA vaccine platform

Compare Gritstone bio, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Gritstone bio, Inc. operates in Biotechnology - Immunotherapy & Oncology. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Immunotherapy & Oncology research →
NEW · MCP server

Ask your AI assistant about Gritstone bio, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Gritstone bio, Inc. and its top competitor on Cyborg Score”
“What did Gritstone bio, Inc. do this quarter?”
“Is Gritstone bio, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Gritstone bio, Inc. do?+
Gritstone bio discovers, develops, manufactures and delivers next generation cancer and infectious disease immunotherapy candidates. The company uses self-amplifying mRNA (samRNA) and chimpanzee adenovirus (ChAd) vect...
What is Gritstone bio, Inc.'s Cyborg Score?+
Gritstone bio, Inc. has a Cyborg Score of 2/10 (Challenged). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Gritstone bio, Inc.'s main competitors?+
Named competitors include Moderna, BioNTech, Inovio. The full competitive landscape is in the AskCyborg report.
How can I get the full Gritstone bio, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Gritstone bio, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Gritstone bio, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual